Marianne J Davies, NP

Clinical Instructor in Nursing

Specialties & Subspecialties

Cancer Center, Yale: Thoracic Oncology Program | Supportive Oncology Program

Education & Training

    Patient Care

    Accepts New Patients? Yes | Patient Type: Adult | Accepts referrals from patients


    Clinical Interests

    Melanoma; renal cell cancer; symptom management; survivorship; clinical research; skin SPORE


    Cancers Treated

    Sarcoma


    Board Certifications

    • Clinical Specialist in Medical-Surgical Nursing, Board Certified (1999)
    • Acute Care Nurse Practitioner, Board Certified (2001)

    Clinical Trials

    Conditions Study Title
    Breast Cancer (ER, PR, and HER2 negative), Colorectal Cancer, Endometrial Cancer, Gastric Adenocarcinoma, Glioblastoma Multiforme, Head/ Neck Squamous Cell Carcinoma, Melanoma, Non-Small Cell Lung Cancer (NSCLC), Ovarian Cancer, Prostate Cancer, Brain and Nervous System, Breast - Female, Breast - Male, Colon, Lip, Oral Cavity and Pharynx, Lung, Melanoma, skin, Other Female Genital, Ovary, Prostate, Rectum, and Stomach A Phase I/IIa, First Time in human, open-label dose-escalation study of GSK2636771 in subjects with advanced solid tumors with PTEN deficiency
    Lung A Phase 1b Open-label Study to Evaluate the Safety and Tolerability of MEDI4736 in Combination with Tremelimumab in Subjects With Advanced Non-Small Cell Lung Cancer
    Bladder, Breast - Female, Lung, Pancreas, and Stomach A Phase 1/2, Open-label Study of Nivolumab Monotherapy or Nivolumab combined with Ipilimumab in Subjects with Advanced or Metastatic Solid Tumors
    Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered With Concurrent Cisplatin Versus Docetaxel Versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck (RTOG 1216)
    Lung and Melanoma, skin A Phase 2 Study of MK-3475 in patients with metastatic melanoma and non-small cell lung cancer with untreated brain metastases

    More Clinical Trials...

    Edit Profile